CN105412299A - Tetrapanax papyriferus combined medicine for treating acute mastitis - Google Patents

Tetrapanax papyriferus combined medicine for treating acute mastitis Download PDF

Info

Publication number
CN105412299A
CN105412299A CN201510866414.7A CN201510866414A CN105412299A CN 105412299 A CN105412299 A CN 105412299A CN 201510866414 A CN201510866414 A CN 201510866414A CN 105412299 A CN105412299 A CN 105412299A
Authority
CN
China
Prior art keywords
gram
radix
medicine
acute mastitis
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510866414.7A
Other languages
Chinese (zh)
Inventor
张爱萍
韦富林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510866414.7A priority Critical patent/CN105412299A/en
Publication of CN105412299A publication Critical patent/CN105412299A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides tetrapanax papyriferus combined medicine for treating acute mastitis. The medicine is characterized by being prepared from, by weight, 40-50 g of white mulberry root bark, 40-50 g of bulbus fritillariae cirrhosae, 40-50 g of radix scutellariae, 40-50 g of radix angelica sinensis, 40-50 g of almond, 20-25 g of leeches, 20-25 g of dried orange peel, 20-25 g of costusroot, 20-25 g of polygala tenuifolia, 20-25 g of fructus schizandrae, 20-25 g of nidus vespae and 20-25 g of liquorice. The materials are smashed and packaged, and the medicine is obtained. The medicine has the advantages of being suitable for large-scale production, low in production cost and the like.

Description

The Medulla Tetrapanacis composition of medicine for the treatment of acute mastitis
Technical field
The present invention relates to a kind of Chinese patent medicine, particularly a kind of instant particles as Chinese medicine.
Background technology
Mastitis are the common diseases of women, can be divided into acute purulent mammitis, mammary areola other fistula, plasma cell mastitis etc., modal acute purulent mammitis according to the difference of the cause of disease.Acute purulent mammitis often betides age of sucking, particularly in 1 ~ 2 month puerperal of primipara, therefore cry again acute age of sucking or puerperal suppurative mastitis, the traditional Chinese medical science is called " acute mastitis ".The sickness rate of primipara's acute mastitis up to 2% ~ 4%, more than multipara's mastitis 1 times.Human milk silt occurs together bacteriological infection and falling ill, and shows, red and swollen heat pain, the high heat of shiver with cold in acute inflammation, in early days can maneuver milk ejection, and treatment by Chinese herbs, then needs incision and drainage after suppurating.
Summary of the invention
The object of the invention is to: propose a kind of Medulla Tetrapanacis composition of medicine for the treatment of acute mastitis.
The Medulla Tetrapanacis composition of medicine for the treatment of acute mastitis of the present invention, is characterized in that: by weight, by Medulla Tetrapanacis 40-50 gram, Flos Lonicerae 40-50 gram, Herba Taraxaci 40-50 gram, Radix Bupleuri 20-25 gram, Radix Salviae Miltiorrhizae 20-25 gram, Radix Paeoniae Rubra 20-25 gram, Fructus Aurantii Immaturus 20-25 gram, Radix Glycyrrhizae 6-10 gram, Borneolum Syntheticum 2 grams; Pulverize, packaging, obtains product.
Function cures mainly: promoting blood circulation and cooling blood, phlegm-eliminiating and qi-regulating.Cure mainly acute mastitis.
Packaging: can be every pouch 30g or every bag of 500 grams of-1000 grams of specifications.
Usage: pour medicated powder 30g into electric cup, 10-15 minute after the 200ml that adds water boils, gets liquid and uses; 1 day 3 times for oral administration.
The Medulla Tetrapanacis composition of medicine for the treatment of acute mastitis of the present invention, is characterized in that: by weight, by Medulla Tetrapanacis 40-50 gram, Flos Lonicerae 40-50 gram, Herba Taraxaci 40-50 gram, Radix Bupleuri 20-25 gram, Radix Salviae Miltiorrhizae 20-25 gram, Radix Paeoniae Rubra 20-25 gram, Fructus Aurantii Immaturus 20-25 gram, Radix Glycyrrhizae 6-10 gram, Borneolum Syntheticum 2 grams; Adopt the method for prior art, make Tablet and Capsula product.
The present invention has the following advantages and effect: the advantages such as it has raw material and is easy to get, and cost is low, and therapeutic effect is remarkable.
Detailed description of the invention
Below in conjunction with test and clinical trial situation, technical scheme of the present invention is described in further detail.
Embodiment 1
The Medulla Tetrapanacis composition of medicine for the treatment of acute mastitis of the present invention, is characterized in that: by weight, by Medulla Tetrapanacis 40-50 gram, Flos Lonicerae 40-50 gram, Herba Taraxaci 40-50 gram, Radix Bupleuri 20-25 gram, Radix Salviae Miltiorrhizae 20-25 gram, Radix Paeoniae Rubra 20-25 gram, Fructus Aurantii Immaturus 20-25 gram, Radix Glycyrrhizae 6-10 gram, Borneolum Syntheticum 2 grams; Pulverize, packaging, obtains product.
Function cures mainly: promoting blood circulation and cooling blood, phlegm-eliminiating and qi-regulating.Cure mainly acute mastitis.
Packaging: can be every pouch 30g or every bag of 500 grams of-1000 grams of specifications.
Usage: pour medicated powder 30g into electric cup, 10-15 minute after the 200ml that adds water boils, gets liquid and uses; 1 day 3 times for oral administration.
Embodiment 2
The Medulla Tetrapanacis composition of medicine for the treatment of acute mastitis of the present invention, is characterized in that: by weight, by Medulla Tetrapanacis 50 grams, and Flos Lonicerae 50 grams, Herba Taraxaci 50 grams, Radix Bupleuri 25 grams, Radix Salviae Miltiorrhizae 20 grams, Radix Paeoniae Rubra 20 grams, Fructus Aurantii Immaturus 20 grams, 6 grams, Radix Glycyrrhizae, Borneolum Syntheticum 2 grams; Pulverize, packaging, obtains product.
Function cures mainly: promoting blood circulation and cooling blood, phlegm-eliminiating and qi-regulating.Cure mainly acute mastitis.
Packaging: can be every pouch 30g or every bag of 500 grams of-1000 grams of specifications.
Usage: pour medicated powder 30g into electric cup, 10-15 minute after the 200ml that adds water boils, gets liquid and uses; 1 day 3 times for oral administration.
Model case:
Lin, female, 27 years old.Puerperal first quarter moon, left breast swelling pain, fear of cold heating 1 week.Examine and see: left breast redness is scorching hot, interior upper limb can touch 3 cm x 4 centimetres scleroma block, touches a tender spot obviously, and milk is not smooth, and pale complexion, rushes tired weak, uncomfortable in chest, and xerostomia is bitter, light red tongue, yellow fur, thready and rapid pulse.Examine as acute mastitis, treat with this side of the present invention; Treat 1 day, swell and ache next day and subtract greatly, cold febrile lysis, after 3 days, all disease knowing are removed, and lump in breast disappears.
Chen, female, 23 years old.The 5th day puerperal is heating suddenly, mammary swelling pain.Certain hospital diagnosis is acute mastitis.Intramuscular injection penicillin with 50% Adlerika soak, treat 2 days invalid.Body temperature 38, lays one's hand on the lump that left breast has 21 centimetre x2 centimetre by 17 DEG C, the enlargement of left axillary lymph knot, breast swell and pain.Check: leukocyte 12300, neutrophilic granulocyte 30%.Treat with this side of the present invention; Treat after 1 day, temperature decline, all diseases alleviate; Connect after controlling 3 days, breast swell and pain disappears, and hemogram recovers normal and heals.

Claims (2)

1. treat a bronchitic Cortex Lycii composition of medicine, it is characterized in that: by weight, by Cortex Lycii 40-50 gram, Radix Scutellariae 40-50 gram, Rhizoma Anemarrhenae 40-50 gram, Rhizoma Fagopyri Dibotryis 40-50 gram, Flos Lonicerae 10-25 gram, Herba Menthae 6-9 gram, Semen Armeniacae Amarum 10-25 gram, Radix Platycodonis 10-25 gram, Radix Peucedani 10-25 gram, Folium Eriobotryae 10-25 gram, Herba Ephedrae 10-25 gram, Gypsum Fibrosum 20-30 gram Flos Farfarae 40-50 gram, Cortex Mori 40-50 gram, Radix Platycodonis 40-50 gram, Radix Stemonae 40-50 gram, Radix Glycyrrhizae 40-50 gram, Periostracum Cicadae 6-25 gram, Bombyx Batryticatus 10-25 gram; Pulverize, packaging, obtains product.
2. treat a Medulla Tetrapanacis composition of medicine for acute mastitis, it is characterized in that: by weight, by Medulla Tetrapanacis 40-50 gram, Flos Lonicerae 40-50 gram, Herba Taraxaci 40-50 gram, Radix Bupleuri 20-25 gram, Radix Salviae Miltiorrhizae 20-25 gram, Radix Paeoniae Rubra 20-25 gram, Fructus Aurantii Immaturus 20-25 gram, Radix Glycyrrhizae 6-10 gram, Borneolum Syntheticum 2 grams; Adopt the method for prior art, make Tablet and Capsula product.
CN201510866414.7A 2015-11-29 2015-11-29 Tetrapanax papyriferus combined medicine for treating acute mastitis Pending CN105412299A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510866414.7A CN105412299A (en) 2015-11-29 2015-11-29 Tetrapanax papyriferus combined medicine for treating acute mastitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510866414.7A CN105412299A (en) 2015-11-29 2015-11-29 Tetrapanax papyriferus combined medicine for treating acute mastitis

Publications (1)

Publication Number Publication Date
CN105412299A true CN105412299A (en) 2016-03-23

Family

ID=55491148

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510866414.7A Pending CN105412299A (en) 2015-11-29 2015-11-29 Tetrapanax papyriferus combined medicine for treating acute mastitis

Country Status (1)

Country Link
CN (1) CN105412299A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107469012A (en) * 2017-09-19 2017-12-15 河南千方药业有限公司 A kind of bavin Chinese herbaceous peony disappears carbuncle tea

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100998792A (en) * 2006-12-26 2007-07-18 章丽美 Oral traditional Chinese for treating acute bronchitis
CN103127432A (en) * 2013-02-02 2013-06-05 孟宪兰 Medicine capable of curing bronchitis
CN104013864A (en) * 2014-05-20 2014-09-03 王伟伟 Traditional Chinese medicine composition for treating bronchitis
CN104435252A (en) * 2014-11-14 2015-03-25 陈绍娟 Medicine for treating acute mastitis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100998792A (en) * 2006-12-26 2007-07-18 章丽美 Oral traditional Chinese for treating acute bronchitis
CN103127432A (en) * 2013-02-02 2013-06-05 孟宪兰 Medicine capable of curing bronchitis
CN104013864A (en) * 2014-05-20 2014-09-03 王伟伟 Traditional Chinese medicine composition for treating bronchitis
CN104435252A (en) * 2014-11-14 2015-03-25 陈绍娟 Medicine for treating acute mastitis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107469012A (en) * 2017-09-19 2017-12-15 河南千方药业有限公司 A kind of bavin Chinese herbaceous peony disappears carbuncle tea

Similar Documents

Publication Publication Date Title
CN101862424B (en) Chinese medicinal composition for treating hepatitis B and preparation method thereof
CN102327452A (en) Chinese patent medicament and Chinese decoction for treating initial carbuncle
CN103495060A (en) Chinese medicine composition for treating infantile jaundice
CN102872369B (en) Traditional Chinese medicine composition for varicella treatment
CN102641419B (en) Traditional Chinese medicine for treating aphonia
CN103610854A (en) Traditional Chinese medicine (TCM) for treating allergic rhinitis
CN104435252A (en) Medicine for treating acute mastitis
CN105412299A (en) Tetrapanax papyriferus combined medicine for treating acute mastitis
CN102451378A (en) Uterus health capsule for treating gynopathy
CN105106756A (en) Traditional Chinese medicine composition for treating age pigment
CN102697984A (en) Chinese medicinal external application preparation for treating acute mastitis
CN105395716A (en) Spina gleditsiae combined medicine for treating acute mastitis
CN102366588A (en) Traditional Chinese medicine for treating nephritis
CN102389498A (en) Traditional Chinese medicine for curing diabetic diarrhea
CN101530596B (en) Capsule for treating mammary gland diseases and preparation method thereof
CN104147341A (en) Traditional Chinese medicine for treating anemia
CN105079378A (en) Traditional Chinese medicine for treating acute renal failure
CN103893566A (en) Giant salamander Chinese herbal medicine compound preparation for treating hepatitis B
CN103800664A (en) Traditional Chinese medicine composition for treating menopausal syndrome
CN103432321A (en) Chinese patent medicine and traditional Chinese medicine decoction both capable of effectively treating abdominal pain due to collapse from qi deficiency
CN103341122A (en) Traditional Chinese medicine composition for treating gallstone
CN106177868A (en) Herba Taraxaci composition of medicine
CN106177870A (en) Spina Gleditsiae composition of medicine
CN103127465A (en) Chinese medicament for treating mammary gland hyperplasia
CN105343201A (en) Rheum officinale composition medicine treating acute mastitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160323